Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By

7 C3 Glomerulopathy Treatment Options That Can Help

Medically reviewed by Madison Ragoonanan, Pharm.D.
Written by Emily Wagner, M.S.
Updated on April 6, 2026

Key Takeaways

  • Complement 3 glomerulopathy is a rare kidney disease that occurs when the immune system becomes overactive and damages the small filters in the kidneys, which can lead to chronic kidney disease or kidney failure if left untreated.
  • View full summary

After receiving a diagnosis of complement 3 glomerulopathy (C3G), it’s natural to feel anxious as you wait for your treatment plan. Doctors usually recommend a combination of lifestyle changes and medications to treat this type of kidney disease. These treatment options are designed to protect kidney function, support overall kidney health, and regulate the immune system to reduce further damage.

This article covers seven types of treatments doctors use for C3G and how these therapies work. To learn more about your treatment plan, talk to your nephrologist (kidney specialist).

What Is C3 Glomerulopathy?

C3G is a set of rare renal diseases that damage the small filters in the kidneys, known as glomeruli. These tiny blood vessels filter toxins and waste from your blood to make urine. The two types of C3G are C3 glomerulonephritis (C3GN) and dense deposit disease (DDD). If you were diagnosed with C3G before 2013, you may know C3GN and DDD as mesangioproliferative or membranoproliferative glomerulonephritis (MPGN).

C3G gets its name from a complement protein called C3. It’s a rare kidney disease that develops when the complement system — part of the immune system that helps fight bacteria and viruses — becomes overactive. Too much C3 then triggers other complement proteins and damages the kidneys.

These proteins form C3-containing deposits (with little or no antibody) that build up in the glomeruli and damage the filters. Over time, this damage can result in chronic kidney disease or even kidney failure if it’s not treated.

Monoclonal Gammopathy and C3G

Some people with C3G have monoclonal gammopathy. In this condition, the immune system makes abnormal antibodies (immune system proteins). If you have C3G and monoclonal gammopathy, your doctor may recommend further evaluation or revise your treatment plan.

In recent years, newer drugs called complement inhibitors have been used to treat C3 glomerulopathy.

C3G treatments focus on calming the immune system to prevent it from attacking the kidneys. In some cases, your care might be led by a hematologist/oncologist who recommends treatments similar to those used in cancer care. The goal of these treatments is to kill the cells that produce the proteins that clog up your kidney filters.

Is C3G a Chronic Kidney Disease?

C3G is a chronic (long-lasting) disease, which means it usually continues over time rather than going away on its own. However, it’s not the same as chronic kidney disease (CKD). CKD is a broad term for many different long-term kidney problems, while C3G is a set of specific rare diseases that can cause CKD by damaging the kidneys. In other words, all C3G is chronic, but not all chronic kidney disease is C3G.

Below are seven ways doctors treat these diseases to improve symptoms and life expectancy with C3G.

1. Healthy Lifestyle Changes

No matter what type of C3G you have, your doctor will likely recommend making healthy lifestyle changes. The overall goal is to support your kidney health and prevent further damage. Treatment may also include medications to help control blood pressure and reduce protein loss. Many people also need additional treatments to manage the disease.

Hypertension (high blood pressure) negatively affects many aspects of health. In the kidneys, the extra pressure on blood vessels causes them to narrow. This narrowing limits blood flow to the kidneys and prevents oxygen and nutrients from reaching the organ tissues. Without enough blood flow, your kidneys can no longer work properly.

Doctors treat high blood pressure by:

  • Prescribing blood pressure drugs, such as ACE inhibitors and angiotensin-receptor blockers (ARBs)
  • Prescribing diuretics (water pills) to get rid of extra fluid in the body, which lowers blood pressure
  • Encouraging limited amounts of sodium in a person’s diet and working with their care team to set individual fluid goals

ACE inhibitors and ARBs also help treat proteinuria, which is extra protein in the urine. Proteinuria is a sign of kidney damage seen in people with C3G.

If you have high cholesterol levels, your doctor may prescribe medication to bring them down. Extra fat or lipids, like cholesterol in your blood, can damage the kidneys. Statins are drugs that help reduce your cholesterol levels and also protect against heart disease.

2. Corticosteroids

Some people with C3G make autoantibodies. These are immune system proteins that attack the body’s own tissues by mistake and switch on the complement system when it isn’t needed. This ongoing activation harms the kidneys.

Corticosteroids are also called steroids. These lab-made medications help control inflammation from an overactive immune system. They work similarly to the hormone cortisol that’s naturally found in the body. Prednisone is a commonly prescribed oral (taken by mouth) corticosteroid that treats inflammatory diseases.

Prednisone can cause many side effects, including weight gain, high blood sugar levels, and blurry vision. It’s important to take prednisone exactly as prescribed and to stop the medication when and how your doctor instructs.

3. Immunosuppressants

Immunosuppressants work by calming the immune system. Doctors sometimes use immunosuppressants to treat C3G because they can stop autoantibodies from attacking the kidneys.

Examples of immunosuppressive medications for C3GN and DDD include:

  • Azathioprine
  • Mycophenolate mofetil
  • Sirolimus
  • Tacrolimus

Doctors sometimes prescribe mycophenolate mofetil with prednisone for C3G as a bridge treatment or to support other therapies, because results can be inconsistent and there are risks associated with long-term use. Common side effects of mycophenolate mofetil include nausea, vomiting, loss of appetite, and sleep problems.

4. Monoclonal Antibodies

Another treatment option for C3G is monoclonal antibodies. Doctors typically prescribe these medications to people when mycophenolate mofetil and prednisone don’t work. Monoclonal antibodies are protein drugs (immunoglobulins) that block a specific part of the immune system.

Eculizumab and ravulizumab are medicines that block part of the immune system called complement protein C5. They are given by intravenous infusions (into a vein). These drugs are not officially approved by the U.S. Food and Drug Administration (FDA) for C3G, but doctors sometimes prescribe them off-label or use them in clinical studies when other treatments don’t work. These drugs, along with newer complement blockers, come with a risk of serious infection.

Rituximab is another antibody medicine that lowers certain immune cells called B cells. Some doctors may try rituximab for C3G, but it’s not FDA-approved for this disease either, and research results have been mixed.

5. Plasma Infusion

If you have moderate to severe C3G and taking mycophenolate mofetil plus prednisone hasn’t worked for you, your doctor may order a plasma infusion. Plasma is the liquid part of blood that contains proteins. A plasma infusion is given to people with factor H defects to replace the missing protein. Factor H defects are genetic conditions in which the body doesn’t have a protein that’s needed to control the immune system properly, which can lead to kidney problems and a higher risk of infections.

Doctors may also use plasma exchange to filter autoantibodies from the blood. A machine then pumps the filtered blood back into the person’s vein. The National Kidney Foundation notes that plasma infusion and plasma exchange are difficult treatments and may not work for everyone.

6. Complement Inhibitors

Doctors and researchers are always looking for new and better ways to treat glomerular diseases like C3G. In recent years, drugs called complement inhibitors, which block specific parts of the complement system, have been increasingly studied as a possible way to treat a variety of diseases, including those that affect the kidneys.

In March 2025, the FDA approved the medicine iptacopan (Fabhalta) for adults with C3G to help lower protein in the urine. This was the first FDA-approved drug for C3G. It’s also approved for the rare kidney disease immunoglobulin A nephropathy (IgAN) and for a rare blood disorder called paroxysmal nocturnal hemoglobinuria (PNH). Iptacopan blocks complement factor B to stop the complement system from attacking the kidneys. It’s taken as an oral tablet.

A few months later, in July 2025, the FDA also approved pegcetacoplan (Empaveli) for people 12 years and older with C3G or a related kidney disease called primary immune complex MPGN (IC-MPGN). Pegcetacoplan has been used to treat PNH, but this is a separate approval for a new use. Pegcetacoplan also works by blocking part of the complement system and helps reduce proteinuria. It’s prescribed selectively by nephrology (kidney) specialists. Pegcetacoplan is given as a subcutaneous (under the skin) injection.

Among side effects for these treatments, both can increase a person’s risk for serious infections. Ask your doctor about how to reduce those risks and what symptoms to watch for.

7. Kidney Transplantation

Some people with C3G have so much kidney damage that they develop end-stage kidney disease (kidney failure). This means their kidneys no longer work well enough to keep them healthy. In most cases, the damaged kidneys aren’t removed.

Kidney transplants may not work for everyone with C3G. Recurrence (return of disease) happens in 55 percent to 86 percent of people with C3G after kidney transplantation, typically soon after the transplant. Recurrence can harm the transplanted kidney and is the second most common cause of graft loss, following rejection.

C3G can also damage the newly transplanted kidney because the body continues to make complement proteins that attack healthy kidney tissue. It’s important to stick with your C3G treatment plan to prevent further damage.

Join the Conversation

On MyKidneyDiseaseTeam, people share their experiences with kidney disease, get advice, and find support from others who understand.

What treatments has your doctor prescribed for C3 glomerulopathy? Let others know in the comments below.

References
  1. Complement 3 Glomerulopathy (C3G) — National Kidney Foundation
  2. Complement 3 Glomerulopathy (C3G) — Cleveland Clinic
  3. Monoclonal Gammopathies — Johns Hopkins Medicine
  4. Monoclonal Gammopathy of Renal Significance — Cleveland Clinic
  5. Chronic Kidney Disease (CKD) — National Kidney Foundation
  6. High Blood Pressure and Kidney Disease — National Institute of Diabetes and Digestive and Kidney Diseases
  7. Diuretics — Mayo Clinic
  8. High Cholesterol and Kidney Disease — National Kidney Federation
  9. C3 Glomerulopathies: Dense Deposit Disease and C3 Glomerulonephritis — Wolters Kluwer UpToDate
  10. Corticosteroids (Glucocorticoids) — Cleveland Clinic
  11. Everolimus — MedlinePlus
  12. Immunosuppressants (Anti-Rejection Medicines) — National Kidney Foundation
  13. Mycophenolate Tablets — Cleveland Clinic
  14. Monoclonal Antibodies — Cleveland Clinic
  15. Updates on C3 Glomerulopathy in Kidney Transplantation: Pathogenesis and Treatment Options — International Journal of Molecular Sciences
  16. Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies — BioMed Research International
  17. Plasma — Cleveland Clinic
  18. Complement Inhibition at the Level of C3 or C5: Mechanistic Reasons for Ongoing Terminal Pathway Activity — Blood
  19. FDA Approves First Treatment for Adults With Complement 3 Glomerulopathy, a Rare Kidney Disease, To Reduce Proteinuria — U.S. Food and Drug Administration
  20. Novartis Receives Third FDA Approval for Oral Fabhalta (Iptacopan) — The First and Only Treatment Approved in C3 Glomerulopathy (C3G) — Novartis
  21. Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy — Kidney International Reports
  22. Novartis Oral Fabhalta (Iptacopan) Sustained Clinically Meaningful Results at One Year in Phase III C3 Glomerulopathy (C3G) Trial — Novartis
  23. Pegcetacoplan: Three Years of Impact in PNH Care — Rare Disease Advisor
  24. Apellis and Sobi Announce Positive Topline Results From Phase 3 Valiant Study of Pegcetacoplan in C3G and Primary IC-MPGN — Apellis
  25. Recurrent C3 Glomerulopathy After Kidney Transplantation — Transplantation Reviews
  26. C3 Glomerulopathy Recurs Early After Kidney Transplantation in Serial Biopsies Performed Within the First Two Years After Transplantation — Clinical Journal of the American Society of Nephrology
  27. Clinical Safety and Efficacy of Pegcetacoplan in a Phase 2 Study of Patients With C3 Glomerulopathy and Other Complement-Mediated Glomerular Diseases — Kidney International Reports
  28. Four Things You May Not Know About Kidney Transplants — NYU Langone Health

Share this article
All updates must be accompanied by text or a picture.
A MyKidneyDiseaseTeam Member

My story pretty much fits into the the article above. Many years prior to my C3GN diagnosis. I'm 68, don't smoke and drink have been a vegatarian for almost 10 years. I had some heart stents inserted… read more

We'd love to hear from you! Please share your name and email to post and read comments.

You'll also get the latest articles directly to your inbox.

Subscriber Photo Subscriber Photo Subscriber Photo
23,898 members
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy Policy Terms of Use
All updates must be accompanied by text or a picture.

Subscribe now to ask your question, get answers, and stay up to date on the latest articles.

Get updates directly to your inbox.

Subscriber Photo Subscriber Photo Subscriber Photo
23,898 members
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy Policy Terms of Use

Thank you for subscribing!

Become a member to get even more

See answer